Mevion Medical Systems and Philips Radiation Oncology Systems have announced a collaboration to combine the treatment planning capability of Philips’ Pinnacle³ radiation therapy planning system with the Mevion S250 proton therapy platform with Hyperscan. Hyperscan is Mevion’s pencil beam scanning technology, which the company says can scan a tumor in seconds.

Pinnacle³ currently supports the S250. The new collaboration will focus on enabling the Pinnacle³ system to also support Hyperscan, which has not yet been cleared by the FDA for clinical use.

The first site to use Pinnacle³ with the S250 is the UF Health Cancer Center at Orlando Health, “This will help lead to well-planned and well-executed proton therapy sessions that accurately target tumors,” Omar Zeidan, PhD, the center’s chief of proton therapy physics, said in a press release.

According to Mevion, the S250’s compact design “removes the obstacles of size, complexity, and cost that exist with conventional proton therapy systems without compromising beam quality or patient care.” The S250 was first installed at Barnes Jewish Hospital in St. Louis. Five other installations are currently in process.